OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SPN56

Sparc Technologies Ltd

Specialty ChemicalsVerified

Sparc Technologies has a fully diluted share count of 119,206,621, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company reported a negative EPS of -0.02 AUD and revenue of 355,000.00 AUD in the latest period. These figures suggest limited profitability and a small revenue base, which is below the median for the Specialty Chemicals industry. The company's return on invested capital (ROIC) and operating margins are not available, making it difficult to assess its efficiency and profitability relative to industry benchmarks. Sparc Technologies does not disclose segment or geographic revenue breakdowns in the available data, which limits the ability to evaluate its exposure to different markets or product lines. This lack of transparency could be a concern for investors seeking to understand the company's diversification and risk profile. The company's growth trajectory is unclear, as no forward-looking revenue or earnings estimates are provided in the available data. The absence of historical revenue growth data further complicates the assessment of its long-term potential. The risk assessment indicates low dilution risk, but liquidity risk remains unassessed due to missing balance-sheet data. No recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance.

30-day price · SPN+0.05 (+28.6%)
Low$0.17High$0.41Close$0.23As of17 May, 00:00 UTC
Profile
CompanySparc Technologies Ltd
TickerSPN.AX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Sparc Technologies Ltd is a specialty chemicals company engaged in the production and distribution of chemical products, primarily serving industrial and commercial markets.

Classification. Sparc Technologies is classified under the Basic Materials economic sector, within the Chemicals business sector and the Specialty Chemicals industry, with a high confidence level of 0.92.

Sparc Technologies has a fully diluted share count of 119,206,621, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company reported a negative EPS of -0.02 AUD and revenue of 355,000.00 AUD in the latest period. These figures suggest limited profitability and a small revenue base, which is below the median for the Specialty Chemicals industry. The company's return on invested capital (ROIC) and operating margins are not available, making it difficult to assess its efficiency and profitability relative to industry benchmarks. Sparc Technologies does not disclose segment or geographic revenue breakdowns in the available data, which limits the ability to evaluate its exposure to different markets or product lines. This lack of transparency could be a concern for investors seeking to understand the company's diversification and risk profile. The company's growth trajectory is unclear, as no forward-looking revenue or earnings estimates are provided in the available data. The absence of historical revenue growth data further complicates the assessment of its long-term potential. The risk assessment indicates low dilution risk, but liquidity risk remains unassessed due to missing balance-sheet data. No recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance.
Key takeaways
  • Sparc Technologies has no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instruments.
  • The company reported a negative EPS of -0.02 AUD and revenue of 355,000.00 AUD, suggesting limited profitability and a small revenue base.
  • No segment or geographic revenue breakdown is available, limiting the ability to assess diversification and risk exposure.
  • Growth trajectory and historical revenue trends are not disclosed, making it difficult to evaluate long-term potential.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4-$5.5M-$5.4M-$5.7M
FY-3$610.8k-$9.5M-$14.2M-$14.2M
FY-2$956.8k-$4.3M-$4.5M-$4.5M
FY-1$1.4M-$3.8M-$4.3M-$4.1M
FY0$2.2M-$1.7M-$2.3M-$2.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$4.0M$3.4M$2.9M
FY-3$4.5M$3.6M$2.1M
FY-2$4.3M$3.5M$3.0M
FY-1$3.5M$2.9M$2.7M
FY0$5.3M$4.2M$3.3M
PeriodOCFCapExFCFSBC
FY-4-$2.4M-$317.0k-$5.7M
FY-3-$4.6M-$218.9k-$14.2M
FY-2-$2.5M-$101.7k-$4.5M
FY-1-$2.2M-$19.0k-$4.1M
FY0-$2.0M-$25.7k-$2.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSPNActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Observations
IR observations
Last actual EPS-0.02 AUD
Last actual revenue355,000.00 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 03:57 UTC#2382df39
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 13:14 UTCJob: 1eff89a2